jCyte update
In spring 2021, the US company jCyte announced detailed results from their successful phase 2b clinical trial of jCell, a stem cell-based treatment for RP.
Search results
In spring 2021, the US company jCyte announced detailed results from their successful phase 2b clinical trial of jCell, a stem cell-based treatment for RP.
The following projects were being funded by Retina UK and have recently come to an end.
Our community is informed and knowledgeable about current research projects into the cause(s) of and treatments for these conditions.
Growth factors are substances that promote the health and function of cells and tissues in the body.
Several groups around the world are investigating the use of retinal transplantation in the treatment of inherited retinal diseases.
Dr Rachel Taylor is part of the UK Inherited Retinal Dystrophy Consortium (UKIRDC) team at the University of Manchester.
Tomasz Tomkiewicz is undertaking a PhD studentship funded by Retina UK and The Macular Society.
Simon spent 40 years as a consultant ophthalmic surgeon at the North Hampshire Hospital in Basingstoke.
Bhavini was diagnosed with RP in 1997 aged 17. The consultant who confirmed her diagnosis told her that “there was no cure or treatment and she should prepare to go blind".
These are some of the most commonly asked questions about genetic testing and counselling.